Company news

Kura Oncology, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Kura Oncology Announces Upcoming Presentation at ASH Annual Meeting

November 5, 2019

Kura Oncology Reports Third Quarter 2019 Financial Results and Provides Corporate Update

November 4, 2019

Kura Oncology Appoints James Basta as Chief Legal Officer

November 3, 2019

Kura Oncology Reports Durable Anti-Tumor Activity in Phase 2 Trial of Tipifarnib in HRAS Mutant Head and Neck Cancer

October 28, 2019

Kura Oncology Announces Upcoming Presentation at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

October 15, 2019

Kura Oncology Expands Board of Directors with Appointment of Diane Parks

October 14, 2019

Kura Oncology Doses First Patient in Phase 1 Clinical Trial of Menin-MLL Inhibitor KO-539 in Acute Myeloid Leukemia

September 15, 2019

← Newer news releases

Calls

The 5 newest of 24 calls. Every call is listed under its year.

Decks

The 5 newest of 54 decks. Every deck is listed under its year.